134 related articles for article (PubMed ID: 21396549)
1. Tigecycline for treating ventilator-associated pneumonia: a practical perspective.
Curcio D
Diagn Microbiol Infect Dis; 2011 Apr; 69(4):466-7. PubMed ID: 21396549
[No Abstract] [Full Text] [Related]
2. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
[TBL] [Abstract][Full Text] [Related]
3. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
Schafer JJ; Goff DA; Stevenson KB; Mangino JE
Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
[TBL] [Abstract][Full Text] [Related]
4. Colistin-tigecycline versus colistin-imipenem-cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study.
Chaari A; Pham T; Mnif B; Chtara K; Medhioub F; Baccouche N; Bahloul M; Hammami A; Bouaziz M
Intensive Care Med; 2015 Nov; 41(11):2018-9. PubMed ID: 26264246
[No Abstract] [Full Text] [Related]
5. Late onset ventilator-associated pneumonia due to multidrug-resistant Acinetobacter spp.: experience with tigecycline.
Curcio D; Fernández F; Vergara J; Vazquez W; Luna CM
J Chemother; 2009 Feb; 21(1):58-62. PubMed ID: 19297274
[TBL] [Abstract][Full Text] [Related]
6. Acinetobacter spp. susceptibility to tigecycline: a worldwide perspective.
Curcio D; Fernández F
J Antimicrob Chemother; 2007 Aug; 60(2):449-50. PubMed ID: 17561503
[No Abstract] [Full Text] [Related]
7. Comparison of the treatment efficacy between tigecycline plus high-dose cefoperazone-sulbactam and tigecycline monotherapy against ventilator-associated pneumonia caused by extensively drug-resistant Acinetobacter baumannii.
Qin Y; Zhang J; Wu L; Zhang D; Fu L; Xue X
Int J Clin Pharmacol Ther; 2018 Mar; 56(3):120-129. PubMed ID: 29319497
[TBL] [Abstract][Full Text] [Related]
8. Tigecycline use in critically ill older patients: case reports and critical analysis.
Curcio D; Fernández F; Duret F
J Am Geriatr Soc; 2007 Feb; 55(2):312-3. PubMed ID: 17302676
[No Abstract] [Full Text] [Related]
9. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia.
Dizbay M; Altuncekic A; Sezer BE; Ozdemir K; Arman D
Int J Antimicrob Agents; 2008 Jul; 32(1):29-32. PubMed ID: 18539006
[TBL] [Abstract][Full Text] [Related]
10. Tigecycline in the treatment of ventilator-associated pneumonia: experience from the Latin American Tigecycline Use Registry.
Curcio D; Castagnino J; Vazquez W; Vergara G; Curiale A;
Infez Med; 2010 Mar; 18(1):27-34. PubMed ID: 20424523
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of minocycline combination therapy for the treatment of patients with ventilator-associated pneumonia due to extensively drug- or pandrug-resistant Acinetobacter baumannii.
Athanassa Z; Manioudaki S; Petsa I; Koumaki V; Sakagianni A; Tsakris A
Int J Antimicrob Agents; 2024 May; 63(5):107129. PubMed ID: 38432603
[No Abstract] [Full Text] [Related]
12. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
[TBL] [Abstract][Full Text] [Related]
13. Tigecycline treatment of critically ill patients: the LatinUser experience.
Curcio D; Vargas SW; Ugarte Ubiergo S; Varón F; Rojas Suarez J; Paz Chávez C; Curiale A;
Curr Clin Pharmacol; 2011 Feb; 6(1):18-25. PubMed ID: 21235466
[TBL] [Abstract][Full Text] [Related]
14. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
Cikman A; Gulhan B; Aydin M; Ceylan MR; Parlak M; Karakecili F; Karagoz A
Int J Med Sci; 2015; 12(9):695-700. PubMed ID: 26392806
[TBL] [Abstract][Full Text] [Related]
15. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.
Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J
Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137
[No Abstract] [Full Text] [Related]
16. Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens.
Poulakou G; Kontopidou FV; Paramythiotou E; Kompoti M; Katsiari M; Mainas E; Nicolaou C; Yphantis D; Antoniadou A; Trikka-Graphakos E; Roussou Z; Clouva P; Maguina N; Kanellakopoulou K; Armaganidis A; Giamarellou H
J Infect; 2009 Apr; 58(4):273-84. PubMed ID: 19344841
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia.
Freire AT; Melnyk V; Kim MJ; Datsenko O; Dzyublik O; Glumcher F; Chuang YC; Maroko RT; Dukart G; Cooper CA; Korth-Bradley JM; Dartois N; Gandjini H;
Diagn Microbiol Infect Dis; 2010 Oct; 68(2):140-51. PubMed ID: 20846586
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections.
Falagas ME; Vardakas KZ; Tsiveriotis KP; Triarides NA; Tansarli GS
Int J Antimicrob Agents; 2014 Jul; 44(1):1-7. PubMed ID: 24602499
[TBL] [Abstract][Full Text] [Related]
19. The role of tigecycline in the treatment of infections in light of the new black box warning.
Dixit D; Madduri RP; Sharma R
Expert Rev Anti Infect Ther; 2014 Apr; 12(4):397-400. PubMed ID: 24597542
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary analysis on the treatment of ventilator-associated pneumonia caused by pandrug-resistant Acinetobacter baumannii].
Wang LW; Zou L; Li HX; Li TZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Apr; 36(2):185-8. PubMed ID: 24791800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
